You are here: Industry Insights > COVID-19 vaccine

News List

Peach State Health Plan and Morehouse School of Medicine Hold Speaker Panel to Discuss COVID-19 Vaccine Hesitation prnewswire
August 02, 2021
Last week, Peach State Health Plan partnered with the Morehouse School of Medicine to host the "Bridging the Gap on the COVID-19 Vaccine" panel to discuss Georgia's ongoing efforts to increase COVID-19 vaccinations across Georgia.
DHL Express delivers US donation of 1.5m Pfizer-BioNTech Covid-19 vaccine doses to Thailand prnasia
July 30, 2021
DHL Express, the world's leading express service provider today successfully delivered the first batch of 1.5 million Pfizer-BioNTech's Covid-19 vaccine doses donated by the United States government to Thailand.
Swedish company ZandCell offers Russia 750 million dose vaccine capacity for Sputnik V and Aurora prnewswire
July 30, 2021
ZandCell, a biotech company with a proven track record in immunotherapies and COVID-19 diagnostics is announcing that it wants to manufacture the Russian vaccines for worldwide distribution.
Study shows AZ’s COVID-19 jab did not increase the rate of rare blood clots after second dose pharmatimes
July 29, 2021
AstraZeneca’s COVID-19 vaccine – Vaxzevria – did not increase the rate of rare blood clots with low platelets after the second dose, according to a new study.
Early data shows CanSinoBIO’s inhaled COVID-19 vaccine triggers immune response pharmatimes
July 29, 2021
CanSinoBIO’s inhaled COVID-19 vaccine candidate was found to trigger immune responses with no serious side effects reported, according to an early-stage clinical study.
Johnson & Johnson Statement on U.S. FDA Approval of Shelf Life Extension for Company’s COVID-19 Vaccine drugs
July 29, 2021
We are pleased to confirm the U.S. Food & Drug Administration (FDA) has extended the shelf life for the Johnson & Johnson single-shot COVID-19 vaccine to six months. The decision is based on data from ongoing stability assessment studies.
EU backs approval of Moderna’s COVID-19 vaccine in 12-17 year-olds pharmatimes
July 28, 2021
Moderna’s COVID-19 vaccine has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for use in adolescents aged 12 to 17 years of age.
Researchers find extending the time between Pfizer doses boosts antibodies pharmatimes
July 27, 2021
UK researchers have found that extending the time between the first and second doses of the Pfizer/BioNTech COVID-19 vaccine boosted antibodies against all variants of the virus tested compared to a short dosing interval.
EMA committee recommends Moderna’s Covid-19 vaccine for adolescents pharmaceutical-technology
July 27, 2021
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the marketing authorisation of the Moderna Covid-19 vaccine, Spikevax, for adolescents aged 12 to 17 years.
AZ says its COVID-19 vaccine protects against severe disease caused by variants pharmatimes
July 26, 2021
AstraZeneca (AZ) has announced that new real-world data from Canada shows its COVID-19 vaccine – Vaxzevria – was found to be highly effective after one dose against severe disease or hospitalisation caused by the Beta and Delta variants.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page